Stay updated with breaking news from Performance Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Enveric Biosciences Inc announced the closing of its underwritten public offering that generated gross proceeds of about $10 million. The company intends to...
Enveric Biosciences Inc announced the closing of its underwritten public offering that generated gross proceeds of about $10 million. The company intends to...
Enveric Biosciences Inc announced the closing of its underwritten public offering that generated gross proceeds of about $10 million. The company intends to...
Toronto, Ontario--(Newsfile Corp. - January 20, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid COVID-19 Rapid Antigen Saliva
The Australian Institute of Company Directors (AICD) has released its annual not-for-profit (NFP) governance and performance study, which reveals while COVID-19’s effects on the sector were not as damaging as predicted many organisations could take years to recover.